Gary W. Pace, Director at Cardiff Oncology, Inc. (CRDF), bought 3,000 shares at $10.58 ($32K) on 2021-03-18, disclosed to the SEC on 2021-03-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.54 | 2,000 | $21K | 66.6% |
| 2 | $10.58 | 1,000 | $11K | 33.4% |
| Total | $10.55 avg | 3,000 | $32K | 100% |
| Filing → |
| CRDF | BUY | 2025-07-31 | $711K | — | Filing → |
| CRDF | BUY | 2024-12-12 | $940K | — | Filing → |
| PCRX | SELL | 2024-03-08 | $4.5M | — | Filing → |